Biodistribution and Dosimetry of 18F-Meta-Fluorobenzylguanidine: A First-in-Human PET/CT Imaging Study of Patients with Neuroendocrine Malignancies-Reference-Cited by-同舟云学术

Biodistribution and Dosimetry of 18F-Meta-Fluorobenzylguanidine: A First-in-Human PET/CT Imaging Study of Patients with Neuroendocrine Malignancies

Published:2017-07-13 Issue:1 Volume:59 Page:147-153
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

Pandit-Taskar Neeta,Zanzonico Pat,Staton Kevin D.,Carrasquillo Jorge A.,Reidy-Lagunes Diane,Lyashchenko Serge,Burnazi Eva,Zhang Hanwen,Lewis Jason S.,Blasberg Ronald,Larson Steven M.,Weber Wolfgang A.,Modak Shakeel

Publisher

Society of Nuclear Medicine

Subject

Radiology, Nuclear Medicine and imaging

Reference24 articles.

1. The International Neuroblastoma Risk Group (INRG) Staging System: An INRG Task Force Report

2. Iodine-123 Metaiodobenzylguanidine Scintigraphy Scoring Allows Prediction of Outcome in Patients With Stage 4 Neuroblastoma: Results of the Cologne Interscore Comparison Study

3. 131I/123I-Metaiodobenzylguanidine (mIBG) scintigraphy: procedure guidelines for tumour imaging

4. MIBG scintigraphy for the diagnosis and follow-up of children with neuroblastoma;Boubaker;Q J Nucl Med Mol Imaging.,2008

5. Scintigraphic Response by 123I-Metaiodobenzylguanidine Scan Correlates With Event-Free Survival in High-Risk Neuroblastoma

Cited by 100 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Theranostics in Neuroendocrine Tumors: Updates and Emerging Technologies;Current Problems in Cancer;2024-10

2. Performing [¹⁸F]MFBG Long–Axial-Field-of-View PET/CT Without Sedation or General Anesthesia for Imaging of Children with Neuroblastoma;Journal of Nuclear Medicine;2024-07-03

3. Molecular Imaging with PET-CT and PET-MRI in Pediatric Musculoskeletal Diseases;Seminars in Nuclear Medicine;2024-05

4. State-of-the-Art Hybrid Imaging of Neuroendocrine Neoplasms;Journal of Computer Assisted Tomography;2024-04-11

5. 3-[18F]Fluoro-para-hydroxyphenethylguanidine (3-[18F]pHPG) PET—A Novel Imaging Modality for Paraganglioma;Journal of the Endocrine Society;2024-04-06